| Autor: |
Nilsen A; VA Medical Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA., LaCrue AN; Department of Global Health, College of Public Health, 3720 Spectrum Blvd. (Ste 304), Tampa, FL 33612, USA., White KL; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., Forquer IP; VA Medical Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA., Cross RM; Department of Chemistry, University of South Florida, 4202 E. Fowler Avenue, Tampa, FL 33620-5250, USA., Marfurt J; Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia., Mather MW; Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, PA 19129, USA., Delves MJ; Department of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom., Shackleford DM; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., Saenz FE; Department of Global Health, College of Public Health, 3720 Spectrum Blvd. (Ste 304), Tampa, FL 33612, USA., Morrisey JM; Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, PA 19129, USA., Steuten J; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., Mutka T; Department of Global Health, College of Public Health, 3720 Spectrum Blvd. (Ste 304), Tampa, FL 33612, USA., Li Y; VA Medical Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA., Wirjanata G; Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia., Ryan E; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., Duffy S; Eskitis Institute for Cell & Molecular Therapies, Brisbane Innovation Park, Nathan campus, Griffith University, QLD 4111, Australia., Kelly JX; VA Medical Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA., Sebayang BF; Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta 10430, Indonesia., Zeeman AM; Department of Parasitology, Biomedical Primate Research Centre, P.O. Box 3306, 2280 GH Rijswijk, The Netherlands., Noviyanti R; Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta 10430, Indonesia., Sinden RE; Department of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom., Kocken CHM; Department of Parasitology, Biomedical Primate Research Centre, P.O. Box 3306, 2280 GH Rijswijk, The Netherlands., Price RN; Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7LJ, UK., Avery VM; Eskitis Institute for Cell & Molecular Therapies, Brisbane Innovation Park, Nathan campus, Griffith University, QLD 4111, Australia., Angulo-Barturen I; GlaxoSmithKline, Medicines Development Campus, Diseases of the Developing World, Severo Ochoa 2, Tres Cantos 28760, Madrid, Spain., Jiménez-Díaz MB; GlaxoSmithKline, Medicines Development Campus, Diseases of the Developing World, Severo Ochoa 2, Tres Cantos 28760, Madrid, Spain., Ferrer S; GlaxoSmithKline, Medicines Development Campus, Diseases of the Developing World, Severo Ochoa 2, Tres Cantos 28760, Madrid, Spain., Herreros E; GlaxoSmithKline, Medicines Development Campus, Diseases of the Developing World, Severo Ochoa 2, Tres Cantos 28760, Madrid, Spain., Sanz LM; GlaxoSmithKline, Medicines Development Campus, Diseases of the Developing World, Severo Ochoa 2, Tres Cantos 28760, Madrid, Spain., Gamo FJ; GlaxoSmithKline, Medicines Development Campus, Diseases of the Developing World, Severo Ochoa 2, Tres Cantos 28760, Madrid, Spain., Bathurst I; Medicines for Malaria Venture, 20, route de Pré-Bois, PO Box 1826, 1215 Geneva 15, Switzerland., Burrows JN; Medicines for Malaria Venture, 20, route de Pré-Bois, PO Box 1826, 1215 Geneva 15, Switzerland., Siegl P; Siegl Pharma Consulting LLC, Blue Bell, PA, USA., Guy RK; Chemical Biology & Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678 USA., Winter RW; VA Medical Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA., Vaidya AB; Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, PA 19129, USA., Charman SA; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., Kyle DE; Department of Global Health, College of Public Health, 3720 Spectrum Blvd. (Ste 304), Tampa, FL 33612, USA., Manetsch R; Department of Chemistry, University of South Florida, 4202 E. Fowler Avenue, Tampa, FL 33620-5250, USA., Riscoe MK; VA Medical Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA.; Department of Molecular Microbiology and Immunology, 3181 Sam Jackson Blvd., Portland, Oregon 97239, USA. |
